Bubonic Plague (Yersinia pestis)

Overview

Plain-Language Overview

Bubonic plague is a serious infectious disease caused by the bacterium Yersinia pestis. It primarily affects the lymphatic system, leading to swollen and painful lymph nodes called buboes. The infection usually starts after a bite from an infected flea, which transmits the bacteria from rodents to humans. Symptoms include sudden fever, chills, headache, and weakness, along with the characteristic buboes in the groin, armpit, or neck. If untreated, the infection can spread to the bloodstream or lungs, causing more severe illness. The disease mainly impacts the body's ability to fight infection and can be life-threatening without prompt medical care.

Clinical Definition

Bubonic plague is an acute zoonotic infection caused by the gram-negative bacillus Yersinia pestis. It is characterized by the rapid onset of fever, chills, and painful bubo formation due to lymphadenitis in regional lymph nodes. The disease is transmitted primarily through the bite of infected fleas that have fed on infected rodents, making it a vector-borne illness. The core pathology involves bacterial proliferation within lymph nodes, leading to intense inflammation and necrosis. If untreated, the infection can progress to septicemic or pneumonic plague, which have higher mortality rates. The disease is historically significant for causing large epidemics and remains a public health concern in endemic areas. Diagnosis and early treatment are critical to prevent systemic spread and fatal outcomes.

Inciting Event

Bite from an infected flea carrying Yersinia pestis is the primary inciting event.
Direct contact with infected animal tissues or fluids can also initiate infection.
Inhalation of infectious droplets may lead to secondary pneumonic plague but is less common for bubonic form.

Latency Period

Incubation period typically ranges from 2 to 6 days after flea bite before symptom onset.
Symptoms usually develop rapidly within the first week following exposure.

Diagnostic Delay

Nonspecific early symptoms such as fever and malaise can mimic common infections, delaying diagnosis.
Lack of awareness in non-endemic areas leads to missed or late consideration of plague.
Failure to recognize characteristic buboes or obtain appropriate cultures delays confirmation.
Limited access to specialized laboratory testing for Yersinia pestis identification.

Patient Population

Adults and children in endemic rural areas are most commonly affected by bubonic plague.
Individuals with outdoor exposure to rodent habitats or flea-infested environments.
Both sexes are equally affected with no significant sex predilection.
Populations with limited access to healthcare have higher morbidity and mortality rates.

Risk Factors

Exposure to infected fleas from wild rodents or domestic animals increases risk of infection.
Living in endemic areas such as rural regions with poor sanitation and high rodent populations.
Occupational exposure in hunters, veterinarians, or laboratory workers handling infected animals.
Immunosuppression increases susceptibility to severe infection and complications.
Close contact with infected animals or handling carcasses without protective measures.

Clinical Presentation

Signs & Symptoms

Sudden onset of high fever and chills
Painful, swollen lymph nodes (buboes) near flea bite or entry site
Headache and malaise
Fatigue and myalgias
Gastrointestinal symptoms such as nausea and vomiting in severe cases

History of Present Illness

Sudden onset of high fever and chills followed by severe malaise and headache.
Development of painful, swollen lymph nodes (buboes) near the flea bite site, commonly inguinal or axillary.
Associated symptoms include myalgia, nausea, and vomiting during systemic illness.
Progression to septicemia or secondary pneumonic plague may occur if untreated.

Past Medical History

Previous exposure to endemic environments or history of flea bites increases suspicion.
Immunocompromising conditions such as HIV or malignancy worsen disease severity.
Prior antibiotic use may mask or alter clinical presentation delaying diagnosis.

Family History

[]

Physical Exam Findings

Tender, swollen lymph nodes (buboes) typically in the inguinal, axillary, or cervical regions
Fever and chills with associated diaphoresis
Tachycardia and hypotension in severe cases indicating systemic involvement
Petechiae or purpura may be present in septicemic plague
Signs of septic shock such as altered mental status and cold extremities

Diagnostic Workup

Diagnostic Criteria

Diagnosis of bubonic plague is established by identifying the characteristic bubo in a patient with compatible symptoms such as fever and chills. Definitive diagnosis requires isolation of Yersinia pestis from clinical specimens such as bubo aspirate, blood, or sputum using culture techniques. Additional confirmation can be obtained by polymerase chain reaction (PCR) testing or detection of specific F1 antigen by immunofluorescence. Serologic tests may support diagnosis but are less useful in acute settings. Clinical suspicion should be high in patients with relevant exposure history and typical presentation.

Pathophysiology

Key Mechanisms

Transmission via flea bite introduces Yersinia pestis into the skin, leading to local infection.
Bacterial proliferation in lymph nodes causes painful, swollen buboes characteristic of bubonic plague.
Endotoxin release from Yersinia pestis triggers systemic inflammatory response and sepsis.
Inhibition of phagocytosis by bacterial virulence factors allows immune evasion and dissemination.
Microvascular thrombosis and necrosis contribute to tissue damage and gangrene in severe cases.

Involvement	Details
Organs	Lymph nodes become enlarged and necrotic due to bacterial proliferation and immune response, producing the hallmark buboes.
	Spleen may become enlarged and involved in systemic infection and immune response.
	Lungs can be affected in secondary pneumonic plague, leading to respiratory failure and transmission risk.
Tissues	Lymphatic tissue is the primary site of Yersinia pestis replication, leading to characteristic swollen and painful buboes.
Tissues	Vascular endothelium is involved in bacterial dissemination and contributes to vascular leakage and hemorrhage.
Cells	Macrophages phagocytose Yersinia pestis but the bacteria can survive intracellularly, facilitating dissemination.
	Neutrophils are recruited to infected lymph nodes and contribute to inflammation and abscess formation.
	Dendritic cells present Yersinia pestis antigens to initiate adaptive immune responses.
Chemical Mediators	Tumor necrosis factor-alpha (TNF-α) mediates systemic inflammation and fever in bubonic plague.
	Interleukin-1 beta (IL-1β) promotes local inflammation and recruitment of immune cells to infected tissues.
	Lipopolysaccharide (LPS) from Yersinia pestis triggers strong innate immune activation and septic shock in severe cases.

Treatments

Pharmacological Treatments

Streptomycin
- Mechanism:
  - Inhibits bacterial protein synthesis by binding the 30S ribosomal subunit of Yersinia pestis.
- Side effects:
  - Ototoxicity
  - Nephrotoxicity
  - Neuromuscular blockade
- Clinical role:
  - First-line
Gentamicin
- Mechanism:
  - Binds the 30S ribosomal subunit to inhibit protein synthesis in Yersinia pestis.
- Side effects:
  - Nephrotoxicity
  - Ototoxicity
  - Neuromuscular blockade
- Clinical role:
  - First-line
Doxycycline
- Mechanism:
  - Inhibits bacterial protein synthesis by binding the 30S ribosomal subunit, effective against Yersinia pestis.
- Side effects:
  - Photosensitivity
  - Gastrointestinal upset
  - Tooth discoloration in children
- Clinical role:
  - Alternative first-line
Ciprofloxacin
- Mechanism:
  - Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication in Yersinia pestis.
- Side effects:
  - Tendonitis
  - Gastrointestinal upset
  - QT prolongation
- Clinical role:
  - Alternative first-line

Non-pharmacological Treatments

Isolation of infected patients to prevent transmission via respiratory droplets.
Supportive care including fluid resuscitation and oxygen therapy for systemic illness.
Surgical drainage of buboes if abscess formation occurs.

Prevention

Pharmacological Prevention

Doxycycline prophylaxis for high-risk exposures
Streptomycin or gentamicin as post-exposure prophylaxis in endemic areas
Tetracycline or ciprofloxacin for chemoprophylaxis in exposed individuals
No widely available vaccine currently recommended for general use
Prompt antibiotic treatment of suspected cases to prevent spread

Non-pharmacological Prevention

Avoidance of flea bites through insect repellents and protective clothing
Rodent control measures to reduce reservoir populations
Use of personal protective equipment when handling potentially infected animals
Quarantine and isolation of infected individuals to prevent transmission
Public health surveillance and education in endemic regions

Outcome & Complications

Complications

Septic shock with multiorgan failure
Disseminated intravascular coagulation (DIC) causing bleeding and thrombosis
Secondary pneumonic plague from hematogenous spread
Meningitis due to central nervous system invasion
Death if untreated or delayed treatment

Short-term Sequelae	Long-term Sequelae
Resolution of buboes with appropriate antibiotic therapy Residual lymphadenopathy or scarring at bubo sites Transient renal impairment from sepsis Post-infectious fatigue Secondary bacterial infections at bubo sites	Chronic lymphedema in affected lymph node regions Permanent scarring or fibrosis of skin and lymph nodes Psychological impact from severe illness or disfigurement Rare neurologic deficits if meningitis occurred No known chronic carrier state

Differential Diagnoses

Bubonic Plague (Yersinia pestis) versus Tularemia

Bubonic Plague (Yersinia pestis)	Tularemia
Contact with fleas from rodents or endemic areas	Contact with rabbits or ticks in rural areas
Caused by Yersinia pestis	Caused by Francisella tularensis
Positive culture or PCR for Yersinia pestis	Positive serology or culture for Francisella tularensis
Buboes are typically painful and swollen lymph nodes	Ulceroglandular form with painless ulcer and regional lymphadenopathy

Bubonic Plague (Yersinia pestis) versus Cat Scratch Disease

Bubonic Plague (Yersinia pestis)	Cat Scratch Disease
History of flea bite or rodent exposure	History of cat scratch or bite
Caused by Yersinia pestis	Caused by Bartonella henselae
Acute onset with high fever and rapid progression	Subacute regional lymphadenopathy with mild systemic symptoms
Positive culture or PCR for Yersinia pestis	Positive serology or PCR for Bartonella henselae

Bubonic Plague (Yersinia pestis) versus Lymphogranuloma Venereum

Bubonic Plague (Yersinia pestis)	Lymphogranuloma Venereum
Exposure to flea bites or endemic rodent areas	Sexual contact with infected partner
Caused by Yersinia pestis	Caused by Chlamydia trachomatis serovars L1-L3
Acute febrile illness with painful buboes	Chronic, progressive lymphadenopathy with genital ulcers
Positive culture or PCR for Yersinia pestis	Positive nucleic acid amplification test for Chlamydia trachomatis

Bubonic Plague (Yersinia pestis) versus Staphylococcal or Streptococcal Lymphadenitis

Bubonic Plague (Yersinia pestis)	Staphylococcal or Streptococcal Lymphadenitis
Caused by Yersinia pestis	Caused by Staphylococcus aureus or Streptococcus pyogenes
Buboes with systemic symptoms and septicemia	Localized lymph node infection with abscess formation
Gram-negative bipolar staining rods on microscopy	Gram-positive cocci on culture and microscopy
Requires aminoglycosides or tetracyclines for effective treatment	Responds well to beta-lactam antibiotics

Bubonic Plague (Yersinia pestis) versus Tularemic Pneumonia

Bubonic Plague (Yersinia pestis)	Tularemic Pneumonia
Inhalation or flea bite with systemic spread of Yersinia pestis	Inhalation of aerosolized Francisella tularensis
Secondary pneumonia following bubonic or septicemic plague	Primary pneumonia with cough and chest pain
Caused by Yersinia pestis	Caused by Francisella tularensis
Positive culture or PCR for Yersinia pestis	Positive culture or PCR for Francisella tularensis